Sandra L. Silberman
Equibles does not estimate personal net worth.
About Sandra L. Silberman
The proxy statement of CNS Pharmaceuticals, Inc. reports total compensation of $720,818 for Sandra L. Silberman in fiscal 2025, including a base salary of $495,000. Disclosed compensation is on record for 7 fiscal years.
Affiliation history
-
CNS Pharmaceuticals, Inc. (CNSP)
Proxy statement
Start not stated–2025-10-24
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | CNS Pharmaceuticals, Inc. (CNSP) | Former Chief Medical Officer | $495,000 | $720,818 |
| 2024 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Medical Officer | $200,000 | $361,641 |
| 2023 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Medical Officer | $200,000 | $270,152 |
| 2022 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Medical Officer | $200,000 | $281,306 |
| 2021 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Medical Officer | $200,000 | $269,238 |
| 2020 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Medical Officer | $175,000 | $340,958 |
| 2019 | CNS Pharmaceuticals, Inc. (CNSP) | Chief Medical Officer | $23,333 | $272,721 |
Recent activity
No call appearances or filed executive changes recorded yet.